Middlesex University
The Burroughs, Hendon, London, Greater London, United Kingdom
Program Summary
A degree in Pharmaceutical Sciences will provide students with a broad understanding of the drug development process. Students will learn key concepts in chemistry and biology related to pharmaceutical sciences and explore areas such as, pharmacology, toxicology, drug design, delivery, and manufacturing, as well as regulatory affairs related to drug development.
Students should study this degree if they are interested in learning how medicines are developed and how they interact with the body. This degree will prepare students for a career in the pharmaceutical industry where they can contribute to the development of new drugs and make an impact on people’s lives.
Students will have the opportunity to:
- be taught by academic staff with strong links and long experience in the pharmaceutical industry
- apply knowledge to practice in Middlesex University's newly renovated dedicated chemical and pharmaceutical laboratories
- attend visiting lectures from industrial experts delivering workshops on drug development case studies and clinical trials
- develop business acumen and innovative thinking through a dedicated module in science innovation
- apply for summer research studentships available from the relevant professional bodies
Academic Background
Minimum Level of Education Completed
1-Year Post-Secondary Certificate
Minimum GPA
55%
Minimum Language Test Scores
TOEFL
72
IELTS
6
Reading
5.5
Writing
5.5
Listening
5.5
Speaking
5.5
PTE
59
Reading
59
Writing
59
Listening
59
Speaking
59
Program Intakes
September 2025
Open date
September 20, 2024
Submission deadline
July 1, 2025
September 2026
Open date
September 20, 2025
Submission deadline
July 1, 2026
Cost and Duration
3-Year Bachelor's Degree
Program Level
1 year pathway (foundation year) followed by a 3 year bachelor's degree
Program Length
£16008 GBP
Cost of Living
£0 GBP
Application fee
£16600 GBP / First Year
Gross Tuition
Study Destinations
© 2005-2025 PIE Academy Inc.